» Articles » PMID: 8481497

Epidemiology of the M-component Immunoglobulin Types of Multiple Myeloma

Overview
Specialties Oncology
Public Health
Date 1993 Mar 1
PMID 8481497
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this population-based case-control study was to learn whether risk factors differ for the individual immunoglobulin types of multiple myeloma. In particular, we sought to determine whether IgA and IgG myeloma were related to a history of exposure to reported IgA- and IgG-stimulating conditions, respectively, or to a history of selected occupational and physicochemical exposures. The M-component immunoglobulin type was determined from immunoelectrophoresis as reported in medical records, and exposure status was obtained through in-person interviews. IgG (56 percent) and IgA (22 percent) M-components predominated. For 17 percent of cases, no peak was found on immunoelectrophoresis; they were presumed to have light-chain myeloma. Persons with these three types of myeloma did not differ with respect to distributions of age or race, but a somewhat higher proportion of light-chain cases were women (58 percent cf 45 percent of all other cases). Detailed analysis of the IgA and IgG subtypes provided little evidence that they differ with respect to prior immune stimulation or employment in several specific jobs. IgA myeloma, but not IgG myeloma, was associated modestly with a history of exposure to chest and dental X-rays. Our study provides little evidence that IgA and IgG myeloma differ with respect to the risk factors examined.

Citing Articles

Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation.

Lewis D, Pottern L, Brown L, Silverman D, Hayes R, Schoenberg J Cancer Causes Control. 1994; 5(6):529-39.

PMID: 7827240 DOI: 10.1007/BF01831381.

References
1.
Turneer M, van Vooren J, Nyabenda J, Legros F, Lecomte A, Thiriaux J . The humoral immune response after BCG vaccination in humans: consequences for the serodiagnosis of tuberculosis. Eur Respir J. 1988; 1(7):589-93. View

2.
Ameno S, Ameno K, Fuke C, Kiryu T, Ijiri I . IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans. Toxicon. 1990; 28(3):347-50. DOI: 10.1016/0041-0101(90)90070-n. View

3.
Koepsell T, Daling J, Weiss N, Taylor J, Olshan A, Lyon J . Antigenic stimulation and the occurrence of multiple myeloma. Am J Epidemiol. 1987; 126(6):1051-62. DOI: 10.1093/oxfordjournals.aje.a114744. View

4.
Eriksson M, Karlsson M . Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med. 1992; 49(2):95-103. PMC: 1012073. DOI: 10.1136/oem.49.2.95. View

5.
Wisloff F, Andersen P, Andersson T, Brandt E, Eika C, Fjaestad K . Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. I. Eur J Haematol. 1991; 47(5):333-7. DOI: 10.1111/j.1600-0609.1991.tb01856.x. View